The Role of Nitric Oxide in Inflammation

Advances in Immunology

Volumn 60, Issue C, 1995, Pages 323-371

  Lyons, C Rick ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE; NITRIC OXIDE;

ARTHRITIS; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; DIABETES MELLITUS; EDEMA; ENDOTHELIUM; IMMUNE COMPLEX DISEASE; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY CELL; PAIN; PRIORITY JOURNAL; REVIEW; VASODILATATION; WOUND HEALING;

ANIMAL; CELL MOVEMENT; CYTOKINES; ENDOTHELIUM; HUMAN; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTES; MICE; MODELS, IMMUNOLOGICAL; NITRIC OXIDE; T-LYMPHOCYTES;

EID: 0028875195     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/S0065-2776(08)60589-1     Document Type: Article

References (299)

1. Abu-Soud, H.M., Stuehr, D.J., Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc. Natl. Acad. Sci. USA 90 (1993), 10769–10772.
2. Adams, L.B., Franzblau, S.G., Vavrin, Z., Hibbs, J.B. Jr., Krahenbuhl, J.L., L-Arginine dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J. Immunol. 147 (1991), 1642–1646.
3. Adams, L.B., Hibbs, J.B. Jr., Taintor, R.R., Krahenbuhl, J.L., Microbostatic effect of murine-activated macrophages for Toxoplasma gondii: Role for synthesis of inorganic nitrogen oxides from l-arginine. J. Immunol. 144 (1990), 2725–2729.
4. Albina, J., Cui, S., Mateo, R.B., Reichner, J.S., Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 50 (1993), 5080–5085.
5. Albina, J.E., Abate, J.A., Henry, W. Jr., Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147 (1991), 144–148.
6. Albina, J.E., Mills, C.D., Henry, W.L., Caldwell, M.D., Temporal expression of different pathways of I-arginine metabolism in healing wounds. J. Immunol. 144 (1990), 3877–3880.
7. Albina, J.E., Mills, C.D., Barbul, A., Thirkill, C.E., Henry, W.L., Mastrofrancesco, B., Caldwell, M.D., Arginine metabolism in wounds. Am. J. Physiol. 17 (1988), E459–E467.
8. Ramadi, Al-B.K., Meissler, J. Jr., Huang, D., Eisenstein, T.K., Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur. J. Immunol. 22 (1992), 2249–2254.
9. Alspaugh, J.A., Granger, D., Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect. Immun. 59 (1991), 2291–2296.
10. Andrews, F.J., Malcontenti-Wilson, C., O'Brien, P.E., Protection against gastric ischemia-reperfusion injury by nitric oxide generators. Digestive Dis. Sci. 39 (1994), 366–373.
11. Assreuy, J., Cunha, F.Q., Liew, F.Y., Moncada, S., Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br. J. Pharmacol. 108 (1993), 833–837.
12. Azuma, H., Ishikawa, M., Sekizaki, S., Endothelium-dependent inhibition of platelet aggregation. Br. J. Pharmacol. 88 (1986), 411–415.
13. Bancroft, G.J., Schreiber, R., Unanue, E.R., Natural immunity: A T-cell-independent pathway of macrophage activation, defined in the SCID mouse. Immunol. Rev. 124 (1991), 5–24.
14. Barnes, P.J., Belvisi, M.G., Nitric oxide and lung disease. Thorax 48 (1993), 1034–1043.
15. Bartsch, H., Ohshima, H., Pignatelli, B., Calmels, S., Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics 2 (1992), 272–277.
16. Beasley, D., Eldridge, M., Interleukin-1 beta and tumor necrosis factor-alpha synergistically induce NO synthase in rat vascular smooth muscle cells. Am. J. Physiol. 266:Part 2 (1994), R1197–R1203.
17. Beasley, D., Schwartz, J.H., Brenner, B.M., Interleukin 1 induces prolonged l-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest. 87 (1991), 602–608.
18. Beckerman, K.P., Rogers, J.A., Corbett, R.D.C., Schreiber, M.L., Unanue, E.R., Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J. Immunol. 150 (1993), 888–895.
19. Benninghoff, B., Lehmann, V., Eck, H.P., Droge, W., Production of citrulline and ornithine by interferon-gamma treated macrophages. Int. Immunol. 3 (1991), 413–417.
20. Bernhardt, J., Tschudi, M.R., Dohi, Y., Gut, I., Urwyler, B., Buhler, F.R., Luscher, T.F., Release of nitric oxide from human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 180 (1991), 907–912.
21. Billiar, T.R., Curran, R.D., Stuehr, D.J., West, M.A., Bentz, B.G., Simmons, R.L., An l-arginine dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis. J. Exp. Med. 169 (1989), 1467–1471.
22. Billiau, A., Vandekerchove, F., Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur. J. Clin. Invest. 21 (1991), 559–573.
23. + T lymphocytes differ in their ability to activate macrophage antileischmanial defense. J. Leukocyte Biol. 51 (1992), 296–299.
24. Bogdan, C., Vodovotz, Y., Paik, J., Xie, Q.W., Nathan, C., Traces of bacterial lipopolysaccharide suppress IFN-gamma-induced nitric oxide synthase gene expression in primary mouse macrophages. J. Immunol. 151 (1993), 301–309.
25. Bogdan, C., Vodovotz, Y., Paik, J., Xie, Q.W., Nathan, C., Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J. Leukocyte Biol. 55 (1994), 227–233.
26. Bogle, R.G., Baydoun, A.R., Pearson, J.D., Moncada, S., Mann, G.E., L-Arginine transport is increased in macrophages generating nitric oxide. Biochem. J. 284:Part 1 (1992), 15–18.
27. Bogle, R.G., Coade, S.B., Moncada, S., Pearson, J.D., Mann, G.E., Bradykinin and ATP stimulate l-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem. Biophys. Res. Commun. 180 (1991), 926–932.
28. Boughton-Smith, N.K., Evans, S.M., Laszlo, F., Whittle, B.J., Moncada, S., The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br. J. Pharmacol. 110 (1993), 1189–1195.
29. Boulanger, C., Luscher, T.F., Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85 (1990), 587–590.
30. Bredt, D.S., Hwang, P.M., Glatt, C.E., Lowenstein, C., Reed, R.R., Snyder, S.H., Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351 (1991), 714–718.
31. Bredt, D.S., Hwang, P.M., Snyder, S.H., Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347 (1990), 768–770.
32. Bredt, D.S., Snyder, S.H., Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA 86 (1989), 9030–9033.
33. Bredt, D.S., Snyder, S.H., Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87 (1990), 682–685.
34. Brune, B., Lapetina, E.G., Phosphorylation of nitric oxide synthase by protein kinase A. Biochem. Biophys. Res. Commun. 181 (1991), 921–926.
35. Buelow, R., O'Hejir, R.E., Schreifels, R., Kummerehl, T.J., Riley, G., Lamb, J., Localization of the immunologic activity in the superantigen Staphylococcal entertoxin B using truncated recombinant fusion proteins. J. Immunol. 148 (1992), 1–6.
36. Buttery, L.D., McCarthy, A., Springall, D.R., Sullivan, M.H., Elder, M.G., Michel, T., Polak, J.M., Endothelial nitric oxide synthase in the human placenta: Regional distribution and proposed regulatory role at the feto-maternal interface. Placenta 15 (1994), 257–265.
37. Cameron, M.L., Granger, D.L., Weinberg, J.B., Kozumbo, W.J., Koren, H.S., Human alveolar and peritoneal macrophages mediate fungistasis independently of l-arginine oxidation to nitrite and nitrate. Am. Rev. Respir. Dis. 142 (1990), 1313–1323.
38. Chan, J., Xing, Y., Magliozzo, R.S., Bloom, B.R., Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175 (1992), 1111–1122.
39. Chan, S.H., Kobayashi, M., Santoli, D., Perussia, B., Trinchieri, G., Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J. Immunol. 148 (1992), 92–98.
40. Charles, I.G., Palmer, R.M., Hickery, M.S., Bayliss, M.T., Chubb, A.P., Hall, V.S., Moss, D.W., Moncada, S., Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc. Natl. Acad. Sci. USA 90 (1993), 11419–11423.
41. Cho, H.J., Xie, Q.W., Calalcay, J., Mumford, R.A., Swiderek, K.M., Lee, T.D., Nathan, C., Calmodulin is a subunit of nitric oxide synthase from macrophages. J. Exp. Med. 176 (1992), 599–604.
42. Cocks, T.M., Angus, J.A., Campbell, J.H., Campbell, G.R., Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. J. Cell. Physiol. 123 (1985), 310–320.
43. Cohen, I.R., Autoimmunity to chaperonins in the pathogenesis of artritis and diabetes. Annu. Rev. Pharmacol. 9 (1991), 567–589.
44. Cooke, J.P., Rossitch, E., Andon, N.A., Loscalzo, J., Dzau, V.J., Flow activates an endothelial potassium channel to release endogenous nitrovasodilator. J. Clin. Invest. 88 (1991), 1663–1671.
45. Corbett, J.A., Lancaster, J.R., Sweetland, M.A., McDaniel, M.L., Interleukin 1b-induced formation of EPR-detectable iron-nitrosyl complexes in Islets of Langerhans: Role of nitric oxidein Interleukin 1β-induced inhibition of insulin secretion. J. Biol. Chem. 266 (1991), 21351–21354.
46. Corbett, J.A., Wang, J.L., Hughes, J.H., Wolf, B.A., Sweetland, M.A., Lancaster, J. Jr., McDaniel, M.L., Nitric oxide and cGMP formation induced by interleukin 1 b in islets of Langerhans: Evidence for an effector role of nitric oxide in islet dysfunction. Biochem. J. 287 (1992), 229–235.
47. Corbett, J.A., Sweetland, M.A., Wang, J.L., Lancaster, J. Jr., McDaniel, M.L., Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. Sci. USA 90 (1993), 1731–1735.
48. Culotta, E., Koshland, D.E., NO news is good news. Science 258 (1992), 1862–1865.
49. Cunha, F.Q., Lorenzetti, B.B., Poole, S., Ferreira, S.H., Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol. 104 (1991), 765–767.
50. Deng, W., Thiel, B., Tannenbaum, C.S., Hamilton, T.A., Stuehr, D.J., Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages. J. Immunol. 151 (1993), 322–329.
51. Denham, S., Rowland, I.J., Inhibition of the reactive proliferation of lymphocytes by activated macrophages: The role of nitric oxide. Clin. Exp. Immunol. 87 (1992), 157–162.
52. Denis, M., Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 132 (1991), 150–157.
53. Denis, M., Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: Killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukocyte Biol. 49 (1991), 380–387.
54. Dijkmans, R., Billiau, S., Interferon-gamma/lipopolysaccharide-treated mouse embryonic fibroblasts are killed by a glycolysis/l-arginine-dependent process accompanied by depression of mitochondrial respiration. Eur. J. Biochem. 202 (1991), 151–159.
55. Ding, A., Nathan, C.F., Steuhr, D.J., Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141 (1988), 2407–2412.
56. Di Rosa, M., Radomski, M., Carnuccio, R., Moncada, S., Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172 (1990), 1246–1252.
57. DiRosa, M., Giroud, J.P., Willoughby, D.A., Studies of mediators of the acute inflammatory response induced in rats in different sites by carageenin and turpentine. J. Pathol. 104 (1971), 15–23.
58. Doherty, T.M., Kastelein, R., Menon, S., Andrade, S., Coffman, R.L., Modulation of murine macrophage function by IL-13. J. Immunol. 151 (1993), 7151–7160.
59. Duarte, I.D.G., Dos Santos, I.R., Lorenzetti, B.B., Ferreira, S.H., Analgesia by direct antagonism of nociceptor sensitization involves the l-arginine: Nitric oxide:cGMP pathway. Eur. J. Pharmacol. 217 (1992), 225–232.
60. Duarte, I.D.G., Lorenzetti, B.B., Ferreira, S.H., Peripheral analgesia and activation of the nitric oxide cyclic GMP pathway. Eur. J. Pharmacol. 186 (1990), 289–295.
61. Dumarey, C.H., Labrousse, V., Rastogi, N., Vargaftig, B.B., Bachelet, M., Selective Mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages. J. Leukocyte Biol. 56 (1994), 36–40.
62. Dvorak, A.M., Monahan, R.A., Osage, J.E., Dickersin, G.R., Crohn's disease: Transmission electron microscopic studies II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils and the microvasculature. Hum. Pathol. 11 (1980), 606–619.
63. Evans, T.G., Thai, L., Granger, D.L., Hibbs, J. Jr., Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J. Immunol. 151 (1993), 907–915.
64. Farrell, A.J., Blake, D.R., Palmer, R.M.J., Moncada, S., Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51 (1992), 1219–1228.
65. Fehsel, K., Jalowy, A., Qi, S., Burkart, V., Hartmann, B., Kolb, H., Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 42 (1993), 496–500.
66. Ferreira, S.H., The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs 46 (1993), 1–9.
67. Ferreira, S.H., Lorenzetti, B.B., Bristow, A.F., Poole, S., Interleukin 1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334 (1988), 698–700.
68. ++ dependent process. Prostaglandins 18 (1979), 179–190.
69. Fischer-Stenger, K., Marciano-Cabral, F., The arginine-dependent cytolytic mechanism plays a role in destruction of Naegleria fowleri amoebae by activated macrophages. Infect. Immun. 60 (1992), 5126–5131.
70. Flesch, I.E., Kaufmann, S.H., Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: Role of reactive nitrogen intermediates. Infect. Immun. 59 (1991), 3213–3218.
71. Florquin, S., Amraoui, Z., Dubois, C., Decuyper, J., Goldman, M., The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J. Exp. Med. 180 (1994), 1153–1158.
72. Flynn, J.L., Chan, J., Triebold, K.J., Dalton, D.K., Stewart, T.A., Bloom, B.R., An essential role for interferon γ in resistance to Mycobacterium tuberculosis. J. Exp. Med. 178 (1993), 2249–2254.
73. Forstermann, U., Closs, E.I., Pollock, J.S., Nakane, M., Schwarz, P., Gath, I., Kleinert, H., Nitric oxide synthase isozymes. Characterization, purification, molecuar cloning, and functions. Hypertension 23:Part 2 (1994), 1121–1131.
74. Forstermann, U., Pollock, J.S., Schmidt, H., Heller, M., Murad, F., Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88 (1991), 1788–1792.
75. Forstermann, U., Gorsky, L.D., Pollock, J.S., Ishii, K., Schmidt, H.H., Heller, M., Murad, F., Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol. Pharmacol. 38 (1990), 7–13.
76. Fortier, A.H., Polsinelli, T., Green, S.J., Nacy, C.A., Activation of macrophages for destruction of Francisella tularensis: Identification of cytokines, effector cells, and effector molecules. Infect. Immun. 60 (1992), 817–825.
77. Fu, Y., Blankenhorn, E.P., Nitric oxide-induced anti-mitogenic effects in high and low responder rat strains. J. Immunol. 148 (1992), 2217–2222.
78. Fujihara, M., Connolly, N., Ito, N., Suzuki, T., Properties of protein kinase C isoforms (beta II, epsilon, and zeta) in a macrophage cell line (J774) and their roles in LPS-induced nitric oxide production. J. Immunol. 152 (1994), 1898–1906.
79. Fujihara, M., Ito, N., Pace, J.L., Watanabe, Y., Russell, S.W., Suzuki, T., Role of endogenous interferon-beta in lipopolysaccharide-triggered activation of the inducible nitric-oxide synthase gene in a mouse macrophage cell line, J774. J. Biol. Chem. 269 (1994), 12773–12778.
80. Furchgott, R.F., The role of endothelium in the responses of vascular smooth muscle to drugs. Annu. Rev. Pharmacol. Toxicol. 24 (1984), 175–197.
81. Furchgott, R. F. (1988). Studies on relaxation of rabbit aorta by sodium nitrite: The basis for the proposal that the acid activatable inhibitory factor from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In “Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium” (P. M. Vanhoutte, Ed.), pp. 401–414.
82. Furchgott, R.F., Zawadzki, J.V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (London) 288 (1980), 373–376.
83. Furlong, B., Henderson, A.H., Lewis, M.J., Smith, J.A., Endothelium derived relaxing factor inhibits in vitro platelet aggregation. Br. J. Pharmacol. 90 (1987), 373–376.
84. Gaboury, J., Woodman, R.C., Granger, D.N., Reinhardt, P., Kubes, P., Nitric oxide prevents leukocyte adherence: Role of superoxide. Am. J. Physiol. 265 (1993), H862–H867.
85. Garbers, D.L., The guanylyl cyclase receptor family. New Biol. 2 (1990), 499–504.
86. Garbers, D.L., Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell 74 (1992), 1–4.
87. Garthwaite, J., Garthwaite, G., Palmer, R.M.J., Moncada, S., NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 172 (1989), 413–416.
88. Gazzinelli, R.T., Oswald, I.P., James, S.L., Sher, A., IL-10 inhibits parasite killing and nitrogen oxide production by IFN- gamma-activated macrophages. J. Immunol. 148:6 (1992), 1792–1798.
89. Geller, D.A., Lowenstein, R.A., Shapiro, R.A., Nussler, A.K., DiSilvio, M., Way, S.C., Nalaysan, D.K., Simon, R.L., Snyder, S.H., Billiar, T.R., Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA 90 (1993), 3461–3465.
90. Geller, D.A., Nussler, A.K., Di Silvio, M., Lowenstein, C.J., Shapiro, R.A., Wang, S.C., Simmons, R.L., Billiar, T.R., Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. USA 90 (1993), 522–526.
91. Geng, J.G., Bevilacqua, M.P., Moore, K.L., McIntyre, T.M., Prescott, S.M., Kim, J.M., Bliss, G.A., Zimmerman, G.A., McEver, R.P., Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature (London) 343 (1990), 757–760.
92. Geng, Y.J., Petersson, A.S., Wennmalm, A., Hansson, G.K., Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells. Exp. Cell. Res. 214 (1994), 418–428.
93. Gilbert, R.S., Herschman, H.R., Transforming growth factor beta differentially modulates the inducible nitric oxide synthase gene in distinct cell types. Biochem. Biophys. Res. Commun. 195:1 (1993), 380–384.
94. Granger, D.L., Hibbs, J.B.J., Perfect, J.R., Durack, D.T., Metabolic fate of I-arginine in relation to microbiostatic capability of murine macrophages. J. Clin. Invest. 85 (1990), 264–273.
95. Granger, D.L., Perfect, J.R., Durack, T.T., Macrophage-mediated fungistasis in vitro: Requirements for intracellular cytotoxicity. J. Immunol. 136 (1986), 672–680.
96. Granger, D.L., Taintor, R.R., Cook, J.L., Hibbs, J.B. Jr., Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. J. Clin. Invest. 65 (1980), 357–370.
97. L.A., Green, D.A., Wagner, J., Glogowski, P.L., Skipper, J.S., Wishnock, S.R., Tannenbaum, Analysis of nitrate, nitrite, and [15 N]nitrate in biological fluids, Anal. Biochem., (1982), 1256, 131-138
98. Green, L.C., Ruiz de Luzuriaga, K., Wagner, D.A., Rand, W., Istfan, N., Young, V.R., Tannenbaum, S.R., Nitrate biosynthesis in man. Proc. Natl. Acad. Sci. USA 78 (1981), 7764–7768.
99. Green, L.C., Tannenbaum, S.R., Goldman, R., Nitrate synthesis in the germfree and conventional rat. Science 212 (1981), 56–58.
100. Green, S.G., Meltzer, M.S., Hibbs, J.B. Jr., Nacy, C.A., Activated macrophages destroy intracellular Leishmania major amastigotes by an I-arginine dependent killing mechanism. J. Immunol. 144 (1990), 278–283.
101. Green, S.J., Crawford, R.M., Hockmeyer, J.T., Meltzer, M.S., Nacy, C.A., Leishmania major amastigotes initate the l-arginine dependent killing mechanism in IFNg-stimulated macrophages by induction of tumor necrosis factor-alpha. J. Immunol. 145 (1993), 4290–4297.
102. Green, S.J., Nacy, C.A., Schreiber, R.D., Granger, D.L., Crawford, R.M., Meltzer, M.S., Fortier, A.R., Neutralization of gamma interferon and tumor necrosis alpha blocks in vivo synthesis of nitrogen oxides from l-arginine and protection against Francisella tularensis in Mycobacterium bovis (Bcg) treated mice. J. Immunol. 149 (1993), 689–698.
103. Griffith, T.M., Edwards, D.H., Lewis, M.J., Newby, A.C., Henderson, A.H., The nature of endothelium-derived vascular relaxant factor. Nature (London) 308 (1984), 645–647.
104. Griffiths, M.J., Messent, M., MacAllister, R.J., Evans, T.W., Aminoguanidine selectivity inhibits inducible nitric oxide synthase. Br. J. Pharmacol. 110 (1993), 963–968.
105. Grisham, M.B., Ware, K., Gilleland, J.H.E., Gilleland, L.B., Abelli, C.L., Yamada, T., Neutrophil-mediated nitrosamine formation: role of nitric oxide in rats. Gastroenterology 103 (1992), 1260–1266.
106. Groschner, K., Graier, W.F., Kukovetz, W.R., Activation of a small-conductance Ca(2+)-dependent K+ channel contributes to bradykinin-induced stimulation of nitric oxide synthesis in pig aortic endothelial cells. Biochim. Biophys. Acta 1137 (1992), 162–170.
107. Gross, S.S., Levi, R., Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J. Biol. Chem. 267 (1992), 25722–25729.
108. Gross, S.S., Levi, R., Madera, A., Park, K.H., Vane, J., Hattori, Y., Tetrahydrobiopterin synthesis is induced by LPS in vascular smooth muscle and is rate-limiting for nitric oxide production. Adv. Exp. Med. Biol. 338 (1993), 295–300.
109. Gross, S.S., Stuehr, D.J., Aisaka, K., Jaffe, E.A., Levi, R., Griffith, O.W., Macrophage and endothelial cell nitric oxide synthesis: Cell-type selective inhibition by NG-aminoarginine, NG-nitroarginine and NG- methylarginine. Biochem. Biophys. Res. Commun. 170 (1990), 96–103.
110. Gryglewski, R.J., Botting, R.M., Vane, J.R., Mediators produced by the endothelial cell. Hypertension 12 (1988), 530–548.
111. Gryglewski, R.J., Palmer, R.M.J., Moncada, S., Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature (London) 320 (1986), 454–456.
112. Harbrecht, B.G., Billiar, T.R., Stadler, J., Demetris, A.J., Ochoa, J.B., Curran, R.D., Simmons, R.L., Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit. Care Med. 20 (1992), 1568–1574.
113. Hattori, Y., Campbell, E.B., Gross, S.S., Argininosuccinate synthetase mRNA and activity are induced by immunostimulants in vascular smooth muscle. Role in the regeneration or arginine for nitric oxide synthesis. J. Biol. Chem. 269 (1994), 9405–9408.
114. Heck, D.E., Laskin, D.L., Gardner, C.R., Laskin, J.D., Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J. Biol. Chem. 267 (1992), 21277–21280.
115. Heiss, L.N., Lancaster, J. Jr., Corbett, J.A., Goldman, W.E., Epithelial autotoxicity of nitric oxide: Role in the respiratory cytopathology of pertussis. Proc. Natl. Acad. Sci. USA 91 (1994), 267–270.
116. Hibbs, J.B. Jr., Westenfelder, C., Taintor, R., Vavrin, Z., Kablitz, C., Baranowski, R.L., Ward, J.H., Menlove, R.L., McMurry, M.P., Kushner, J.P., et al. Evidence for cytokine-inducible nitric oxide synthesis from l-arginine in patients receiving interleukin-2 therapy [published erratum appears in J. Clin. Invest. (1992) Jul; 90(1), 295. J. Clin. Invest. 89 (1992), 867–877.
117. Hibbs, J.B. Jr., Taintor, R.R., Vavrin, Z., Macrophage cytotoxcity: Role for l-arginine deiminase activity and imino nitrogen oxidation to nitrite. Science 235 (1987), 473–476.
118. Hibbs, J.B. Jr., Vavrin, Z., Taintor, R.R., L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138 (1987), 550–565.
119. Hoag, K.A., Street, N.E., Lipscomb, M.F., Role of cytokines in the clearance of Cryptococcus neoformans pulmonary infections in mice. FASEB J., 8, 1994, A251.
120. Hogaboam, C.M., Befus, A.D., Wallace, J.L., Modulation of rat mast cell reactivity by IL-1 beta. Divergent effects on nitric oxide and platelet-activating factor release. J. Immunol. 151 (1993), 3767–3774.
121. Hogg, N., Darley-Usmar, V.M., Wilson, M.T., Moncada, S., Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem. J. 281:Part 2 (1992), 419–424.
122. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260 (1993), 547–549.
123. + T cells. J. Exp. Med. 173 (1991), 793–800.
124. Hunt, N.C.A., Goldin, R.D., Nitric oxide production by monocytes in alcoholic liver disease. J. Hepatol. 14 (1992), 146–150.
125. Hutcheson, I.R., Whittle, B.J.R., Boughton-Smith, N.K., Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br. J. Pharmacol. 101 (1990), 815–820.
126. Ialenti, A., Ianaro, A., Moncada, S., Di Rosa, M., Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211 (1992), 177–182.
127. Ialenti, A., Moncada, S., Di Rosa, M., Modulation of adjuvant arthritis by endogenous nitric oxide. Br. J. Pharmacol. 110 (1993), 701–706.
128. Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E., Chaudhuri, G., Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84 (1987), 9265–9269.
129. Ischiropoulos, H., Zhu, L., Beckman, J.S., Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298 (1992), 446–451.
130. Iyengar, R., Stuehr, D.J., Marletta, M.A., Macrophage synthesis of nitrite, nitrate and N-nitrosamines: Precursors in role of the respiratory burst. Proc. Natl. Acad. Sci. USA 84 (1987), 6369–6373.
131. Izumi, Y., Clifford, D.B., Zorumski, C.F., Inhibition of long term potentiation by NMDA-mediated nitric oxide release. Science 257 (1992), 1273–1276.
132. Jacob, T., Morrell, M., Manzi, S., Verdile, V., Simmons, R.L., Elevated nitrates in inflammatory joint disease: Nitric oxide in arthritis. Arthritis Rheum., 35, 1992 R [Abstract].
133. James, J.L., Cook, K.W., Lazdins, J.K., Activation oif human monocyte-derived macrophages to kill schistosomula of Schistosoma mansoni in vitro. J. Immunol. 145 (1990), 2686–2695.
134. James, S.L., Glaven, J., Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependnet production of reactive nitrogen intermediates. J. Immunol. 143 (1989), 4208–4212.
135. Janssens, S.P., Simouchi, A., Quertermous, T., Bloch, D.B., Bloch, K.D., Cloning and expression of a cDNA encoding human endothelium-derived relating factor/nitric oxide synthase. J. Biol. Chem., 267, 1992, 22694.
136. G-nitro-l-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta. Biochem. Biophys. Res. Commun. 199 (1994), 147–154.
137. Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S.I., Kimura, T., Green, S.J., Mak, T.W., Taniguchi, T., Vilcek, J., Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263 (1994), 1612–1615.
138. Kamijo, R., Shapiro, D., Le, J., Huang, S., Aguet, M., Vilcek, J., Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc. Natl. Acad. Sci. USA 90 (1993), 6626–6630.
139. Kanner, J., Harel, S., Granit, R., Nitric oxide as an antioxidant. Arch. Biochem. Biophys. 289 (1991), 130–136.
140. Kelm, M., Feelisch, M., Spahr, R., Piper, H.M., Noack, E., Schrader, J., Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells. Biochem. Biophys. Res. Commun. 154 (1988), 236–244.
141. G-methyl-l-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA 87 (1990), 3629–3632.
142. Kilbourn, R.G., Gross, S.S., Lodato, R.F., Adams, J., Levi, R., Miller, L.L., Lachman, L.B., Griffith, O.W., Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-l-arginine. J. Natl. Cancer. Inst. 84 (1992), 1008–1016.
143. Knowles, R.G., Moncada, S., Nitric oxide synthases in mammals. Biochem. J. 298:Part 2 (1994), 249–258.
144. Knowles, R.G., Palacios, M., Palmer, R.M., Moncada, S., Formation of nitric oxide from l-arginine in the central nervous system. A transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA 86 (1989), 5159–5162.
145. Kobzik, L., Bredt, D.S., Lowenstein, C.J., Drazen, J., Gaston, B., Sugarbaker, D., Stamler, J., Nitric oxide synthase in human and rat lung: Immunocytochemical and histochemical localization. Am. J. Respir. Cell. Mol. Biol. 9 (1993), 371–377.
146. Kroncke, K.D., Fehsel, K., Schmidt, T., Zenke, F.T., Dasting, I., Wesener, J.R., Bettermann, H., Breunig, K.D., Kolb-Bachofen, V., Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9. Biochem. Biophys. Res. Commun. 200 (1994), 1105–1110.
147. Kubes, P., Granger, D.N., Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262 (1992), H611–H615.
148. Kubes, P., Kanwar, S., Niu, X., Gaboury, J.P., Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 7 (1993), 1293–1299.
149. Kubes, P., Suzuki, M., Granger, D.N., Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88 (1991), 4651–4655.
150. Kubrina, L.N., Mikoyan, V.D., Mordvintcev, P.I., Vanin, A.F., Iron potentiates bacterial lipopolysaccharide-induced nitric oxide formation in animal organs. Biochim. Biophys. Acta 1176 (1993), 240–244.
151. Kurose, I., Wolf, R., Grisham, M.B., Granger, D.N., Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ. Res. 74 (1994), 376–382.
152. Lee, K.H., Baek, M.Y., Moon, K.Y., Song, W.K., Chung, C.H., Ha, D.B., Kang, M.S., Nitric oxide as a messenger molecule for myoblast fusion. J. Biol. Chem. 269 (1994), 14371–14374.
153. Lepoivre, M., Chenais, B., Yapo, A., Lemaire, G., Thelander, L., Tenu, J., Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J. Biol. Chem. 265 (1990), 14143–14149.
154. Liew, F.Y., Li, Y., Millott, S., Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145 (1990), 4306–4310.
155. Liew, F.Y., Li, Y., Moss, D., Parkinson, C., Rogers, M.V., Moncada, S., Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur. J. Immunol. 21 (1991), 3009–3014.
156. Liu, R.H., Jacob, J.R., Tennant, B.C., Hotchkiss, J.H., Nitrite and nitrosamine synthesis by hepatocytes isolated from normal woodchucks (Marmota monax) and woodchucks chronically infected with woodchuck hepatitis virus. Cancer Res. 52 (1992), 4139–4143.
157. Liu, S., Adcock, I.M., Old, R.W., Barnes, P.J., Evans, T.W., Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem. Biophys. Res. Commun. 196 (1993), 1208–1213.
158. Lorsbach, R.B., Murphy, W.J., Lowenstein, C.J., Snyder, S.H., Russell, S.W., Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-γ and lipopolysaccharide. J. Biol. Chem. 268 (1993), 1908–1913.
159. Lorsbach, R.B., Russell, S.W., A specific sequence of stimulation is required to induce synthesis of the antimicrobial molecule nitric oxide by mouse macrophages. Infect. Immun. 60 (1992), 2133–2135.
160. Lovchik, J.A., Lyons, C.R., Lipscomb, M.F., A role for nitric oxide in murine immune-mediated lung defenses. FASEB J., 8, 1994, A968.
161. Lowenstein, C., Alley, E.W., Raval, P., Snowman, A.M., Snyder, S., Russell, S.W., Murphy, W.J., Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon-gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90 (1993), 9730–9734.
162. Lowenstein, C.A., Snyder, S.H., Nitric oxide, a novel biological messenger. Cell 70 (1992), 705–707.
163. Lukic, M.L., Stosic-Grujicic, S., Ostojic, N., Chan, W.L., Liew, F.Y., Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice. Biochem. Biophys. Res. Commun. 178 (1991), 913–920.
164. Lyons, C.R., Orloff, G.J., Cunningham, J.M., Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 267 (1992), 6370–6374.
165. Mackaness, G.B., The immunological basis of acquired cellular resistance. J. Exp. Med. 120 (1964), 105–120.
166. Maier, R., Bilbe, G., Rediske, J., Lotz, M., Inducible nitric oxide synthase from human articular chondrocytes: cDNA cloning and analysis of mRNA expression. Biochim. Biophys. Acta 1208 (1994), 145–150.
167. Malawista, S.E., Montgomery, R.R., Van Blaricom, G., Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. A new microbicidal pathway for polymorphonuclear leukocytes. J. Clin. Invest. 90 (1992), 631–636.
168. Maragos, C.M., Andrews, A.W., Keefer, L.K., Elespuru, R.K., Mutagenicity of glyceryl trinitrate (nitroglycerin) in Salmonella typhimurium. Mutat. Res. 298 (1993), 187–195.
169. Marletta, M.A., Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268 (1993), 12231–12234.
170. Marletta, M.A., Nitric oxide synthase: Function and mechanism. Adv. Exp. Med. Biol. 338 (1993), 281–284.
171. Marsden, P.A., Schappert, K.T., Chen, H.S., Flowers, M., Sundell, C.L., Wilcox, J.N., Lamas, S., Michel, T., Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS. Lett. 307 (1992), 287–293.
172. Martin, E., Nathan, C., Xie, Q.W., Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180 (1994), 977–984.
173. Martin, W., Villani, G.M., Jothianandan, D., Furchgott, R.F., Selective blockade of endothelium-dependent and glyceryy trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther. 232 (1985), 708–716.
174. Marumo, T., Nakaki, T., Adachi, H., Esumi, H., Suzuki, H., Saruta, T., Kato, R., Nitric oxide synthase mRNA in endothelial cells: Synergistic induction by interferon-gamma, tumor necrosis factor-alpha and lipopolysaccharide and inhibition by dexamethasone. Jpn. J. Pharmacol. 63 (1993), 327–334.
175. Mautino, G., Paul-Eugene, N., Chanez, P., Vignola, A.M., Kolb, J.P., Bousquet, J., Dugas, B., Heterogenous spontaneous and interleukin-4-induced nitrix oxide production by human monocytes. J. Leukocyte Biol. 56 (1994), 15–20.
176. Mayer, J., Woods, M.L., Vavrin, Z., Hibbs, J. Jr., Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. Infect. Immun. 61 (1993), 491–497.
177. McCall, T.B., Palmer, R.M., Moncada, S., Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur. J. Immunol. 21 (1991), 2523–2527.
178. McCall, T.B., Palmer, R.M.J., Moncada, S., Interleukin-8 inhibits the induction of nitric oxide synthase in rat peritoneal neutrophils. Biochem. Biophys. Res. Commun. 186 (1992), 680–685.
179. McCartney-Francis, N., Allen, J.B., Mizel, D.E., Albina, J.E., Xie, Q., Nathan, C.F., Wahl, S.M., Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178 (1993), 749–754.
180. Mellion, B.T., Ignarro, L.J., Ohlstein, E.H., Pontecorvo, E.G., Hyman, A.L., Kadowitz, P.J., Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57 (1981), 946–955.
181. Michel, T., Lamas, S., Molecular cloning of constitutive endothelial nitric oxide synthase: Evidence for a family of related genes. J. Cardiovasc. Pharmacol. 20 (1992), S45–S49.
182. Michel, T., Li, G.K., Busconi, L., Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 90 (1993), 6252–6256.
183. Miller, M.D., Krangel, M.S., Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12 (1992), 17–46.
184. Mills, C.D., Molecular basis of “suppressor” macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146 (1991), 2719–2723.
185. Mitchell, H.H., Shonle, H.A., Grindley, H.S., The origin of nitrate in the urine. J. Biol. Chem. 24 (1916), 461–470.
186. Miwa, M., Stuehr, D.J., Marletta, M.A., Wishnok, J.S., Tannenbaum, S.R., Nitrosation of amines by stimulated macrophages. Carcinogenesis 8 (1987), 955–958.
187. Miyahara, K., Kawamoto, T., Sase, K., Yui, Y., Toda, K., Yang, L.X., Hattori, R., Aoyama, T., Yamamoto, Y., Doi, Y., et al. Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur. J. Biochem. 223 (1994), 719–726.
188. Moncada, S., Higgs, E.A., Endogenous nitric oxide: physiology, pathology, and clinical relevance. Eur. J. Clin. Invest. 21 (1991), 361–371.
189. Mancada, S., Palmer, R.M., Inhibition of the induction of nitric oxide synthase by glucocorticoids: Yet another explanation for their anti-inflammatory effects?. Trends Pharmacol. Sci. 12 (1991), 130–131.
190. Moncada, S., Palmer, R.M.J., Higgs, E.A., Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:2 (1991), 109–142.
191. G-nitroarginine (NOARG) inhibits endothelium-derived vasodilatation in the rabbit aorta and perfused rat mesentery. Br. J. Pharmacol., 98, 1989, 905.
192. Mosmann, T.R., Role of a new cytokine, interleukin-10, in the cross-regulation of T helper cells. Ann. NY Acad. Sci. 628 (1991), 337–344.
193. Mosmann, T.R., Coffman, R.L., Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46 (1989), 111–147 [Review].
194. Mosmann, T.R., Coffman, R.L., TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 7 (1989), 145–173 [Review].
195. Muller, J.M., Ziegler-Heitbrock, H.W., Baeuerle, P.A., Nuclear factor kappa β, a mediator of lipopolysaccharide effects. Immunobiology 187 (1993), 233–256 [Review].
196. Mulligan, M., Hevel, J.M., Marletta, M.A., Ward, P.A., Tissue injury caused by deposition of immune complexes is l-arginine dependent. Proc. Natl. Acad. Sci. USA 88 (1991), 6338–6342.
197. Mulligan, M.S., Warren, J.S., Smith, C.W., Anderson, D.C., Yeh, C.G., Rudolph, A.R., Ward, P.A., Lung injury after deposition of IgA immune complexes. Requirements for CD18 and arginine. J. Immunol. 148 (1992), 3086–3092.
198. Munoz-Fernandez, M.A., Fernandez, M.A., Fresno, M., Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and IFN-γ through a nitric oxide-dependent mechanism. Immunol. Lett. 33 (1992), 35–40.
199. Munoz-Fernandez, M.A., Fernandez, M.A., Fresno, M., Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur. J. Immunol. 22 (1992), 301–307.
200. Murray, H.W., Teitalbaum, R.F., L-Arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 165 (1992), 513–520.
201. Nakamura, L., Wu-Hsieh, B.A., Howard, D., Recombinant murine gamma interferon stimulates macrophages of the RAW 264.7 cell line to inhibit intracellular growth of Histoplasma capsulatum. Infect. Immun. 62 (1994), 680–684.
202. Nathan, C.F., Nitric oxide as a secretory product of mammalian cells. FASEB J. 6 (1992), 3051–3064.
203. Nathan, C.F., Hibbs, J.B., Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3 (1991), 65–70.
204. Nathan, C.F., Xie, Q.W., Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269 (1994), 13725–13728.
205. Nguyen, T., Brunson, D., Crespi, C.L., Penman, B.W., Wishnok, J.S., Tannenbaum, S.R., DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA 89 (1992), 3030–3034.
206. Nussler, A.K., Billiar, T.R., Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukocyte Biol. 54 (1993), 171–178.
207. Nussler, A.K., Billiar, T.R., Liu, Z.Z., Morris, S. Jr., Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line. Implications for regulation of nitric oxide production. J. Biol. Chem. 269 (1994), 1257–1261.
208. Nussler, A.K., Geller, D.A., Sweetland, M.A., Di Silvio, M., Billiar, T.R., Madariaga, J.B., Simmons, R.L., Lancaster, J. Jr., Induction of nitric oxide synthesis and its reactions in cultured human and rat hepatocytes stimulated with cytokines plus LPS. Biochem. Biophys. Res. Commun. 194 (1993), 826–835.
209. Nussler, A.K., Di Silvio, M., Billiar, T.R., Hoffman, R.A., Geller, D.A., Selby, R., Madariaga, J., Simmons, R.L., Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 176 (1992), 261–264.
210. Ochoa, J.B., Curti, B., Peitzman, A.B., Simmons, R.L., Billiar, T.R., Hoffman, R., Rault, R., Longo, D.L., Urba, W.J., Ochoa, A.C., Increased circulating nitrogen oxides after human tumor immunotherapy: Correlation with toxic hemodynamic changes. J. Natl. Cancer Inst. 84 (1992), 864–867 [Published erratum appears in J. Natl. Cancer Inst. (1992) Aug. 19, 84 (16), 1291].
211. Ochoa, J.B., Udekwu, A.O., Billiar, T.R., Curran, T., Cerra, F.B., Simmons, R., Peitzman, A.B., Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 214 (1991), 621–626.
212. Ohlstein, E.H., Wood, K.S., Ignarro, L.J., Purification and properties of hemedeficient hepatic soluble guanylyl cyclase: Effects of heme and other factors on enzyme activation of NO, NO-heme and protoporphyrin IX. Arch. Biochem. Biophys. 218 (1992), 187–198.
213. O'Connor, K.J., Moncada, S., Glucocorticoids inhibit the induction of nitric oxide synthase and the related cell damage in adenocarcinoma cells. Biochim. Biophys. Acta 1097 (1991), 227–231.
214. Ohshima, H., Bartsch, H., Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat. Res. 305 (1994), 253–264.
215. Oswald, I.P., Wynn, T.A., Sher, A., James, S.L., Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc. Natl. Acad. Sci. USA 89 (1992), 8676–8680.
216. Palmer, R.M., Hickery, M.S., Charles, I.G., Moncada, S., Bayliss, M.T., Induction of nitric oxide synthase in human chrondrocytes. Biochem. Biophys. Res. Commun. 193 (1993), 398–405.
217. Palmer, R.M., Andrews, T., Foxwell, N.A., Moncada, S., Glucocorticoids do not affect the induction of a novel calcium-dependent nitric oxide synthase in rabbit chondrocytes. Biochem. Biophys. Res. Commun. 188 (1992), 209–215.
218. Palmer, R.M., Rees, D.D., Ashton, D.S., Moncada, S., L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153 (1988), 1251–1256.
219. Palmer, R.M.J., Ashton, D.S., Moncada, S., Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature (London) 333 (1988), 664–666.
220. Palmer, R.M.J., Ferrige, A.G., Moncada, S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (London) 327 (1987), 524–526.
221. Park, J., Rikihisa, Y., L-Arginine-dependent killing of intracellular Ehrlichia risticii by macrophages treated with gamma interferon. Infect. Immun. 60 (1992), 3504–3508.
222. Parkin, D.M., Srivatanakul, P., Khlat, M., Chenvidhya, D., Chotiwan, P., Insiripong, S., L'Abbe, K.A., Wild, C.P., Liver cancer in Thailand: I. A case control study of cholangiocarcinoma. Int. J. Cancer 48 (1991), 323–328.
223. Patel, K.D., Zimmerman, G.A., Prescott, S.M., McEver, R.P., McIntyre, T.M., Oxygen radicals induced human endothelial cells to express GMP-140 and bind neutrophils. J. Cell Biol. 112 (1991), 749–759.
224. Perrella, M.A., Yoshizumi, M., Fen, Z., Tsai, J.C., Hsieh, C.M., Kourembanas, S., Lee, M.E., Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells. J. Biol. Chem. 269 (1994), 14595–14600.
225. Petros, A., Bennett, D., Vallance, P., Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338 (1991), 1557–1558.
226. Pfeilschifter, J., Vosbeck, K., Transforming growth factor beta 2 inhibits interleukin 1 beta- and tumour necrosis factor alpha-induction of nitric oxide synthase in rat renal mesangial cells. Biochem. Biophys. Res. Commun. 175 (1991), 372–379.
227. Pietraforte, D., Tritarelli, E., Testa, U., Minetti, M., Gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J. Leukocyte Biol. 55 (1994), 175–182.
228. Porsti, I., Bara, A.T., Busse, R., Hecker, M., Release of nitric oxide by angiotensin-(1–7) from porcine coronary endothelium: Implications for a novel angiotensin receptor. Br. J. Pharmacol. 111 (1994), 652–654.
229. Qi, X., Chen, D., Nottin, R., Mace, L., Herve, P., Weiss, M., Evidence of l-arginine/nitric oxide pathway in endothelium and smooth muscle of human internal mammary artery. Biochem. Biophys. Res. Commun. 195 (1993), 90–96.
230. Radi, R., Beckman, J.S., Bush, K.M., Freeman, B.A., Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266 (1991), 4244–4250.
231. Radi, R., Beckman, J.S., Bush, K.M., Freeman, B.A., Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288 (1991), 481–487.
232. Radomski, M.W., Palmer, R.M., Moncada, S., The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun. 148 (1987), 1482–1489.
233. Radomski, M.W., Palmer, R.M., Moncada, S., Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA 87 (1990), 10043–10047.
234. Radomski, M.W., Palmer, R.M.J., Moncada, S., An l-arginine:nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA 87 (1990), 5193–5197.
235. Rao, K.M., Padmanabhan, J., Kilby, D.L., Cohen, H.J., Currie, M.S., Weinberg, J.B., Flow cytometric analysis of nitric oxide production in human neutrophils using dichlorofluorescein diacetate in the presence of a calmodulin inhibitor. J. Leukocyte Biol. 51 (1992), 496–500.
236. Rees, D.D., Palmer, R.M.J., Moncada, S., Characterization of three inhibitors of endothelial nitric oxide synthase in vivo and in vitro. Br. J. Pharmacol. 101 (1990), 746–752.
237. Reiling, N., Ulmer, A.J., Duchrow, M., Ernst, M., Flad, H.D., Hauschildt, S., Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur. J. Immunol. 24 (1994), 1941–1944.
238. Roach, T.I.A., Kiderlen, A.F., Blackwell, J.M., Role of inorganic nitrogen oxidews and tumor necrosis factor alpha in killingh of Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains. Infect. Immun. 59 (1991), 3935–3944.
239. Rockett, K.A., Awburn, M.M., Cowden, W.B., Clark, I.A., Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect. Immun. 59 (1991), 3280–3283.
240. Rojas, A., Delgado, R., Glaria, L., Palacios, M., Monocyte chemotactic protein-1 inhibits the induction of nitric oxide synthase in J774 cells. Biochem. Biophys. Res. Commun. 196 (1993), 274–279.
241. Rojas, A., Padron, J., Caveda, L., Palacios, M., Moncada, S., Role of nitric oxide pathway in the protection against lethal endotoxemia afforded by low doses of lipopolysaccharide. Biochem. Biophys. Res. Commun. 191 (1993), 441–446.
242. Romani, L., Puccetti, P., Mencacci, A., Cenci, E., Spaccapelo, R., Tonnetti Grohmann, U., Bistoni, F., Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol. 152 (1994), 3514–3521.
243. Rosenberg, S.A., Lotze, M.T., Mule, J.J., New approaches to the immunotherapy of cancer using interleukin-2. Ann. Int. Med. 108 (1988), 853–864.
244. Rubanyi, G.M., Vanhoutte, P.M., Superoxide anions and hyperoxides inactivate endothelium -derived relaxing factor. Am. J. Physiol. 250 (1986), H821–H827.
245. Rubanyi, G.M., Ho, E.H., Cantor, E.H., Lumma, W.C., Parker Botelho, L.H., Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes. Biochem. Biophys. Res. Commun. 181 (1991), 1392–1397.
246. Sakai, N., Kaufman, S., Milstein, S., Tetrahydrobiopterin is required for cytokine-induced nitric oxide production in a murine macrophage cell line (RAW 264). Mol. Pharmacol. 43 (1993), 6–10.
247. Sakai, N., Milstien, S., Availability of tetrahydrobiopterin is not a factor in the inability to detect nitric oxide production by human macrophages. Biochem. Biophys. Res. Commun. 193 (1993), 378–383.
248. Sakuma, I., Stuehr, D.J., Gross, S.S., Nathan, C., Levi, R., Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA 85 (1988), 8664–8667.
249. Salvemini, D., Masini, E., Pistelli, A., Mannaioni, P.F., Vane, J., Nitric oxide: A regulatory mediator of mast cell reactivity. J. Cardiovasc. Pharmacol., 1991, S258–S264 (Suppl. 3).
250. Salvemini, D., Misko, T.P., Masferrer, J.L., Seibert, K., Currie, M.G., Needleman, P., Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90 (1993), 7240–7244.
251. Schmidt, H.H.H., Pollock, J.S., Nakone, M., Gorsky, L.D., Forsterdamm, V., Murad, F., Purification of a soluble isoform of guanylyl cyclose-activating factor synthase. Proc. Natl. Acad. Sci. USA 88 (1991), 365–369.
252. Schmidt, H.H.H.W., Seifert, R., Bohme, E., Formation and release of nitric oxide from human neutrophil and HL-60 cells induced by chemotactic peptide, platelet activating factor and leukotriene B4. FEBS Lett. 244 (1989), 357–360.
253. Schmidt, K., Klatt, P., Mayer, B., Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors. Mol. Pharmacol. 44 (1993), 615–621.
254. Schmidt, K., Werner, E.R., Mayer, B., Wachter, H., Kukovetz, W.R., Tetrahydrobiopterin-dependent formation of endothelium-derived relaxing factor (nitric oxide) in aortic endothelial cells. Biochem. J. 281 (1992), 297–300 (Part 2).
255. Schneemann, M., Schoedon, G., Hofer, S., Blau, N., Guerrero, L., Schaffner, A., Nitric oxide is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167 (1993), 1358–1363.
256. Schoedon, G., Schneemann, M., Blau, N., Edgell, C.J., Schaffner, A., Modulation of human endothelial cell tetrahydrobiopterin synthesis by activating and deactivating cytokines: New perspectives on endothelium-derived relaxing factor. Biochem. Biophys. Res. Commun. 196 (1993), 1343–1348.
257. Schoedon, G., Troppmair, J., Fontana, A., Huber, C., Curtius, H.C., Niederwieser, A., Biosynthesis and metabolism of pterins in peripheral blood mononuclear cells and leukemia lines of man and mouse. Eur. J. Biochem. 166 (1987), 303–310.
258. Sessa, W.C., Harrison, J.K., Barber, C.M., Zeng, D., Durieux, M.E., D'Angelo, D.D., Lynch, K.R., Peach, M.J., Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J. Biol. Chem. 267 (1992), 15274–15276.
259. Sherman, M.P., Loro, M.L., Wong, V.Z., Tashkin, D.P., Cytokine and Pneumocystis carinii-induced l-arginine oxidation by murine and human pulmonary alveolar macrophages. J. Protozool. 38 (1991), 2345–2356.
260. Sheta, E.A., McMillian, K., Masters, B.S.S., Evidence for a bidomain structure of constitutive nitric oxide synthase. J. Biol. Chem. 269 (1994), 15147–15153.
261. Shultz, P.J., Raij, L., Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J. Clin. Invest. 90 (1992), 1718–1725.
262. Simon, A.K., Seipelt, E., Sieper, J., Divergent T-cell cytokine patterns in inflammatory arthritis. Proc. Natl. Acad. Sci. USA 91 (1994), 8562–8566.
263. H.A., Singer, M.J., Peach, Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta, Hypertension, (1982), 4, Supplement II, 19-25
264. Srianujata, S., Tonbuth, S., Bunyaratvej, S., High urinary excretion of nitrosoproline in Opisthorchis subjects. The Relevance of N-Nitroso Compounds to Cancer: Exposures and Mechanisms, 1987, International Agency for Research on Cancer. Lyon, France, 544–546.
265. Stadler, J., Curran, R.D., Ochoa, J.B., Effect of endogenous nitric oxide on mitochondrial respiration of rat hepatocytes in vitro and in vivo. Arch. Surg. 126 (1991), 186–191.
266. Stadler, J.M., Stefanovic, M., Billiar, T.R., Curran, R.D., McIntyre, L.A., Georgescu, H.I., Simmons, R.L., Evans, C.H., Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J. Immunol. 147 (1991), 3915–3925.
267. Stenger, S., Thuring, H., Rollinghoff, M., Bogdan, C., Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180 (1994), 783–793.
268. Stuehr, D.J., Kwon, N.S., Levi, R., Nathan, C., Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. 169 (1989), 1011–1020.
269. Stuehr, D.J., Cho, H.J., Kwon, N.S., Weise, M.F., Nathan, C.F., Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD-and FMN-containing flavoprotein. Proc. Natl. Acad. Sci. USA 88 (1991), 7773–7777.
270. Stuehr, D.J., Marletta, M.A., Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon γ. J. Immunol. 139 (1987), 518–525.
271. Stuehr, D.J., Marletta, M.A., Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 82 (1985), 7738–7742.
272. Stuehr, D.J., Nathan, C.F., Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition of tumor target cells. J. Exp. Med. 169 (1989), 1543–1555.
273. Sudjarwo, S.A., Hori, M., Karaki, H., Effect of endothelin-3 on cytosolic calcium level in vascular endothelium and on smooth muscle contraction. Eur. J. Pharmacol. 229 (1992), 137–142.
274. Summersgill, J.T., Powell, L.A., Buster, B.L., Miller, R.D., Ramirez, J.A., Killing of Legionella pneumophila by nitric oxide in gamma interferon-activated macrophages. J. Leukocyte Biol., 1992, 625–629.
275. Suschek, C., Rothe, H., Fehsel, K., Enczmann, J., Kolb-Bachofen, V., Induction of a macrophage-like nitric oxide synthase in cultured rat aortic endothelial cells. IL-1 beta-mediated induction regulated by tumor necrosis factor-alpha and IFN-gamma. J. Immunol. 151 (1993), 3283–3291.
276. Taylor-Robinson, A.W., Liew, F.Y., Severn, A., Xu, D., McSorley, S.J., Garside, P., Padron, J., Phillips, R.S., Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24 (1994), 980–984.
277. Taylor-Robinson, A.W., Phillips, R.S., Severn, A., Moncada, S., Liew, F.Y., The role of TH1 and TH2 cells in a rodent malaria infection. Science 260 (1993), 1931–1934.
278. Thiemermann, C., Wu, C.C., Szabo, C., Perretti, M., Vane, J.R., Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br. J. Pharmacol. 110 (1993), 177–182.
279. Tomioka, H., Saito, H., Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents. J. Leukocyte Biol. 51 (1992), 24–31.
280. Tonussi, C.R., Ferreira, S.H., Mechanism of diclofenac analgesia: Direct blockade of inflammatory sensitization. Eur. J. Pharmacol. 251 (1994), 173–179.
281. Tsukahara, H., Gordienko, D.V., Goligorsky, M.S., Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 193 (1993), 722–729.
282. Vincendeau, P., Daulouede, S., Macrophage of cytostatic effect on Trypanosoma musculii involves an l-arginine-dependent mechanism. J. Immunol. 146 (1991), 4338–4343.
283. Vodovotz, Y., Bogdan, C., Paik, J., Xie, Q.W., Nathan, C., Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178 (1993), 605–613.
284. Weiss, G., Werner-Felmayer, G., Werner, E.R., Grunewald, K., Wachter, H., Hentze, M.W., Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J. Exp. Med. 180 (1994), 969–976.
285. Weisz, A., Oguchi, S., Cicatiello, L., Esumi, H., Dual mechanism for the control of inducible-type NO synthase gene expression in macrophages during activation by interferon-gamma and bacterial lipopolysaccharide. Transcriptional and post-transcriptional regulation. J. Biol. Chem. 269 (1994), 8324–8333.
286. Werner, E.R., Werner-Felmayer, G., Fuchs, D., Hausen, A., Reibnegger, G., Yim, J.J., Pfleiderer, W., Wachter, H., Biochemistry and function of pteridine synthesis in human and murine macrophages. Pathobiology 59 (1991), 276–285.
287. Werner-Felmayer, G., Werner, E.R., Fuchs, D., Hausen, A., Reibnegger, G., Schmidt, K., Weiss, G., Wachter, H., Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J. Biol. Chem. 268 (1993), 1842–1846.
288. White, K.A., Marletta, M.A., Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 31 (1992), 6627–6631.
289. Wink, D.A., Kasprzak, K.S., Maragos, C.M., Elespuru, R.K., Misra, M., Dunams, T.M., Cebula, T.A., Koch, W.H., Andrew, A.W., Allen, J.S., Keefer, L.K., DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254 (1991), 1001–1003.
290. Winter, C.A., Risley, E.A., Nuss, G.V., Carageenin-induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Prog. Soc. Exp. Biol. Med. 111 (1962), 544–547.
291. Wolin, M.S., Wood, K.S., Ignarro, L.J., Guanylate cyclase from bovine lung. A kinetic analysis of the reglation of the purified soluble enzyme by protoporphyrin IX, heme, and nitrosyl-heme. J. Biol. Chem. 257 (1982), 13312–13320.
292. Wood, E.R., Berger, H. Jr., Sherman, P.A., Lapetina, E.G., Hepatocytes and macrophages express an identical cytokine inducible nitric oxide synthase gene. Biochem. Biophys. Res. Commun. 191 (1993), 767–774.
293. Wright, K.S., Mulsch, A., Busse, R., Osswald, H., Generation of nitric oxide by human neutrophils. Biochem. Biophys. Res. Commun. 160 (1989), 813–819.
294. Xie, Q., Kashiwabara, Y., Nathan, C., Role of transcription factor NF-kB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269 (1994), 4705–4708.
295. Xie, Q., Whisnant, R., Nathan, C., Promoter of the mouse gene encoding calcium-dependent nitric oxide synthase confers inducibly by interferon-gamma and bacterial lipopolysaccharide. J. Exp. Med. 177 (1993), 1779–1784.
296. Xie, Q.W., Cho, H.J., Calaycay, J., Mumford, R.A., Swiderek, K.M., Lee, T.D., Ding, A., Troso, T., Nathan, C., Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256 (1992), 225–228.
297. Yoshida, K., Akaike, T., Doi, T., Sato, K., Ijiri, S., Suga, M., Ando, M., Maeda, H., Pronounced enhancement of NO-dependent antimicrobial action by an NO-oxidizing agent, imidazolineoxyl N-oxide. Infect. Immun. 61 (1993), 3552–3555.
298. Zhang, X., Alley, E.W., Russell, S.W., Morrison, D.C., Necessity and sufficiency of beta interferon for nitric oxide production in mouse peritoneal macrophages. Infect. Immun. 62 (1994), 33–40.
299. Zhang, Z., Morrison, D.C., Lipopolysaccharide-induced selective priming effects on tumor necrosis factor alpha and nitric oxide production in mouser peritoneal macrophages. J. Exp. Med. 177 (1993), 511–516.